Home > Insider Trading > Filing (0001179110-18-006594)

Filing Details

Accession Number:: 0001179110-18-006594
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-05-10 20:38:44
Reporting Period:: 2018-05-08

Accepted Time:: 2018-05-10 20:38:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1428336	Healthequity Inc	HQY	Services-Business Services, Nec (7389)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1614838	Stephen Neeleman	C/O Healthequity, Inc. 15 W. Scenic Pointe Dr., Ste. 100 Draper UT 84020	Founder And Vice Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-05-08	654	$1.25	654	No	4	M	Direct
Common Stock	Acquisiton	2018-05-08	17,185	$14.00	17,839	No	4	M	Direct
Common Stock	Disposition	2018-05-08	17,818	$69.59	21	No	4	S	Direct
Common Stock	Disposition	2018-05-08	21	$70.25	0	No	4	S	Direct
Common Stock	Disposition	2018-05-08	65,744	$69.59	667,541	No	4	S	Indirect	See footnote
Common Stock	Disposition	2018-05-08	74	$70.25	667,467	No	4	S	Indirect	See footnote
Common Stock	Disposition	2018-05-08	21,915	$69.59	231,085	No	4	S	Indirect	See footnote
Common Stock	Disposition	2018-05-08	24	$70.25	231,061	No	4	S	Indirect	See footnote
Common Stock	Acquisiton	2018-05-09	13,926	$14.00	13,926	No	4	M	Direct
Common Stock	Disposition	2018-05-09	10,829	$70.15	3,097	No	4	S	Direct
Common Stock	Disposition	2018-05-09	3,097	$70.66	0	No	4	S	Direct
Common Stock	Disposition	2018-05-09	39,954	$70.15	627,513	No	4	S	Indirect	See footnote
Common Stock	Disposition	2018-05-09	11,426	$70.66	616,087	No	4	S	Indirect	See footnote
Common Stock	Disposition	2018-05-09	13,318	$70.15	217,743	No	4	S	Indirect	See footnote
Common Stock	Disposition	2018-05-09	3,809	$70.66	213,934	No	4	S	Indirect	See footnote
Common Stock	Acquisiton	2018-05-10	8,889	$14.00	8,889	No	4	M	Direct
Common Stock	Disposition	2018-05-10	8,889	$70.21	0	No	4	S	Direct
Common Stock	Disposition	2018-05-10	32,802	$70.21	583,285	No	4	S	Indirect	See footnote
Common Stock	Disposition	2018-05-10	10,934	$70.21	203,000	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	M	Direct
No	4	S	Direct
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2018-05-08	654	$0.00	654	$1.25
Common Stock	Stock Option (right to buy)	Disposition	2018-05-08	17,185	$0.00	17,185	$14.00
Common Stock	Stock Option (Right to Buy)	Disposition	2018-05-09	13,926	$0.00	13,926	$14.00
Common Stock	Stock Option (right to buy)	Disposition	2018-05-10	8,889	$0.00	8,889	$14.00

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2021-08-08	No	4	M	Direct
82,815	2024-07-30	No	4	M	Direct
68,889	2024-07-30	No	4	M	Direct
60,000	2024-07-30	No	4	M	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (right to buy)	$41.28		2027-03-27	19,897	19,897	Direct
Common Stock	Stock Option (right to buy)	$61.72		2028-03-27	14,228	14,228	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2027-03-27	19,897	19,897	Direct
2028-03-27	14,228	14,228	Direct

Footnotes

The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.21 to $70.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (7), (9), (10), (11), (12), (13), (14), (15), (16) and (17) to this Form 4.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Stephen and Christine Neeleman Trust on March 23, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.21 to $70.14, inclusive.
Shares held of record by the Stephen and Christine Neeleman Trust.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Neeleman Family Holdings, LLC, a Utah limited liability company, on March 23, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.21 to $70.14, inclusive.
Shares held of record by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.54 to $70.53, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.54 to $70.89, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.54 to $70.53, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.54 to $70.89, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.54 to $70.53, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.54 to $70.89, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.64 to $70.58, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.64 to $70.58, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.64 to $70.58, inclusive.
The option is immediately exercisable.
The option is exercisable as to 4,974 shares. The option becomes exercisable as to the remaining shares in two annual installments of 4,974 shares on March 27, 2019 and 2020, and in one installment of 4,975 shares on March 27, 2021.
The option becomes exercisable in four equal installments of 3,557 shares on March 27, 2019, 2020, 2021, and 2022.